M
Medmen Enterprises Inc
CNSX:MMEN
Medmen Enterprises Inc
CNSX:MMEN
Price:
0.015
CAD
Market Cap:
CA$20.7m
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
M
|
Medmen Enterprises Inc
CNSX:MMEN
|
US |
|
Camping World Holdings Inc
NYSE:CWH
|
US |
|
Guangdong PAK Corporation Co Ltd
SZSE:300625
|
CN |
|
B
|
BlackBerry Ltd
LSE:0R0P
|
CA |
|
N
|
Natural Beauty Bio-Technology Ltd
HKEX:157
|
HK |
|
Sundrug Co Ltd
TSE:9989
|
JP |
|
L
|
LGL Group Inc
AMEX:LGL
|
US |
|
Equinox Gold Corp
TSX:EQX
|
CA |
|
M
|
Maxicity Holdings Ltd
HKEX:2295
|
HK |
|
A
|
ABx Group Ltd
ASX:ABX
|
AU |
|
Turkiye Is Bankasi AS
IST:ISCTR.E
|
TR |
|
Sichuan Haite High-tech Co Ltd
SZSE:002023
|
CN |
|
2020 Bulkers Ltd
OSE:2020
|
BM |
|
Deckers Outdoor Corp
NYSE:DECK
|
US |
|
China Railway Group Ltd
OTC:CRWOF
|
CN |
|
W
|
WHA Corporation PCL
SET:WHA
|
TH |
|
Beachbody Company Inc
NYSE:BODI
|
US |
Relative Value
There is not enough data to reliably calculate the relative value of MMEN.
Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Relative Valuation FAQ:
MMEN
Relative Value
Base Case
Not Available
Multiples Across Competitors
MMEN Competitors Multiples
Medmen Enterprises Inc Competitors
Medmen Enterprises Inc Competitors
All Countries
| Market Cap | P/S | P/E | EV/EBITDA | EV/EBIT | ||||
|---|---|---|---|---|---|---|---|---|
| US |
M
|
Medmen Enterprises Inc
CNSX:MMEN
|
21.6m CAD | 0.1 | -0.1 | -1.8 | -0.9 | |
| US |
|
Eli Lilly and Co
NYSE:LLY
|
853.2B USD | 13.2 | 41.8 | 28.2 | 30.1 | |
| US |
|
Johnson & Johnson
NYSE:JNJ
|
566.5B USD | 6.1 | 21.5 | 14.9 | 18.3 | |
| CH |
|
Roche Holding AG
SIX:ROG
|
243.4B CHF | 4 | 18.9 | 11.2 | 12.6 | |
| US |
|
Merck & Co Inc
NYSE:MRK
|
288B USD | 4.5 | 16.1 | 10 | 12.1 | |
| UK |
|
AstraZeneca PLC
LSE:AZN
|
214.2B GBP | 5 | 28.5 | 15.8 | 22.3 | |
| CH |
|
Novartis AG
SIX:NOVN
|
225.4B CHF | 5.2 | 21.1 | 13.1 | 16.8 | |
| IE |
E
|
Endo International PLC
LSE:0Y5F
|
237.1B USD | 102.3 | -81.1 | 375.3 | 941.3 | |
| DK |
|
Novo Nordisk A/S
CSE:NOVO B
|
1.1T DKK | 3.5 | 10.4 | 7.7 | 9.1 | |
| US |
|
Pfizer Inc
NYSE:PFE
|
153.3B USD | 2.5 | 20 | 7.7 | 10.2 | |
| US |
|
Bristol-Myers Squibb Co
NYSE:BMY
|
115.5B USD | 2.4 | 16.4 | 7 | 8.6 |
P/S Multiple
P/E Multiple
EV/EBITDA Multiple
EV/EBIT Multiple
